These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38919251)
1. The Serological Evidence of Positive Rheumatoid Factor in Morphea Patients and Its Relation to Disease Severity. Al-Nasrawi AN; Abdulkareem AS; Mohammed Ali MN Cureus; 2024 May; 16(5):e61105. PubMed ID: 38919251 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Histopathologic spectrum of morphea: a single-center retrospective study. Yalçın Ö; Aygün MİŞ; Moustafa E; Aktaş E Dermatol Reports; 2024 Sep; 16(3):9915. PubMed ID: 39290556 [TBL] [Abstract][Full Text] [Related]
5. Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort. Condie D; Grabell D; Jacobe H Arthritis Rheumatol; 2014 Dec; 66(12):3496-504. PubMed ID: 25156342 [TBL] [Abstract][Full Text] [Related]
6. Rheumatoid factor isotypes in localized scleroderma. Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K Clin Exp Dermatol; 2005 Jul; 30(4):405-8. PubMed ID: 15953082 [TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort. Jacobe H; Ahn C; Arnett FC; Reveille JD Arthritis Rheumatol; 2014 Nov; 66(11):3170-7. PubMed ID: 25223600 [TBL] [Abstract][Full Text] [Related]
8. Morphea and Eosinophilic Fasciitis: An Update. Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory arthritis in pediatric patients with morphea. Kashem SW; Correll CK; Vehe RK; Hobday PM; Binstadt BA; Maguiness SM J Am Acad Dermatol; 2018 Jul; 79(1):47-51.e2. PubMed ID: 29535035 [TBL] [Abstract][Full Text] [Related]
10. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review. Kaur S; White S; Bartold M JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and severity of periodontitis in patients with established rheumatoid arthritis and osteoarthritis. Disale PR; Zope SA; Suragimath G; Varma AS; Pisal A J Family Med Prim Care; 2020 Jun; 9(6):2919-2925. PubMed ID: 32984149 [TBL] [Abstract][Full Text] [Related]
12. Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases. Matsushita T; Hasegawa M; Matsushita Y; Echigo T; Wayaku T; Horikawa M; Ogawa F; Takehara K; Sato S Exp Dermatol; 2007 Feb; 16(2):87-93. PubMed ID: 17222220 [TBL] [Abstract][Full Text] [Related]
14. Development and Validation of the Morphea Activity Measure in Patients With Pediatric Morphea. García-Romero MT; Tollefson M; Pope E; Brandling-Bennett HA; Paller AS; Keimig E; Arkin L; Wanat KA; Humphrey SR; Werth VP; Oza V; Jacobe H; Fett N; Cordoro KM; Medina-Vera I; Chiu YE JAMA Dermatol; 2023 Mar; 159(3):299-307. PubMed ID: 36753150 [TBL] [Abstract][Full Text] [Related]
15. The role of skin trauma in the distribution of morphea lesions: a cross-sectional survey of the Morphea in Adults and Children cohort IV. Grabell D; Hsieh C; Andrew R; Martires K; Kim A; Vasquez R; Jacobe H J Am Acad Dermatol; 2014 Sep; 71(3):493-8. PubMed ID: 24880663 [TBL] [Abstract][Full Text] [Related]
16. Using the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) to classify morphoea by severity and identify clinically significant change. Teske NM; Jacobe HT Br J Dermatol; 2020 Feb; 182(2):398-404. PubMed ID: 31049928 [TBL] [Abstract][Full Text] [Related]
17. Association between quality of life and clinical characteristics in patients with morphea. Bali G; Kárpáti S; Sárdy M; Brodszky V; Hidvégi B; Rencz F Qual Life Res; 2018 Oct; 27(10):2525-2532. PubMed ID: 29922914 [TBL] [Abstract][Full Text] [Related]
18. Antibodies against antigens related to scleroderma in a cohort of patients with morphea. Arisi M; Cavazzana I; Cerutti ME; Ferrari F; Carabellese N; Rossi MT; Tincani A; Calzavara-Pinton P; Franceschini F G Ital Dermatol Venereol; 2018 Aug; 153(4):451-458. PubMed ID: 27706114 [TBL] [Abstract][Full Text] [Related]
19. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study. Arif T; Masood Q; Singh J; Hassan I BMC Gastroenterol; 2015 Feb; 15():24. PubMed ID: 25888470 [TBL] [Abstract][Full Text] [Related]
20. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin]. Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]